UBG
GSK icon

United Bank (Georgia)’s GSK GSK Stock Holding History

United Bank (Georgia)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
36,087
-1,996
-5% -$106K 0.58% 48
2026
Q1 		$2.1M Buy
38,083
+747
+2% +$40.5K 0.7% 45
2025
Q4 		$1.83M Sell
37,336
-719
-2% -$33.5K 0.62% 51
2025
Q3 		$1.64M Buy
38,055
+2,782
+8% +$109K 0.57% 55
2025
Q2 		$1.35M Buy
35,273
+2,948
+9% +$113K 0.52% 63
2025
Q1 		$1.25M Buy
32,325
+876
+3% +$32.1K 0.52% 59
2024
Q4 		$1.06M Buy
31,449
+5,664
+22% +$204K 0.45% 59
2024
Q3 		$1.05M Buy
25,785
+1,760
+7% +$72K 0.49% 58
2024
Q2 		$925K Sell
24,025
-4,293
-15% -$181K 0.46% 60
2024
Q1 		$1.21M Buy
28,318
+800
+3% +$33K 0.62% 53
2023
Q4 		$1.02M Buy
27,518
+670
+2% +$24.1K 0.56% 55
2023
Q3 		$973K Buy
26,848
+885
+3% +$31.4K 0.58% 55
2023
Q2 		$925K Sell
25,963
-645
-2% -$23.1K 0.53% 61
2023
Q1 		$947K Buy
26,608
+6,469
+32% +$226K 0.55% 60
2022
Q4 		$708K Buy
+20,139
New +$671K 0.43% 68
2018
Q3 		– Sell
-4,252
Closed -$214K – 78
2018
Q2 		$214K Sell
4,252
-503
-11% -$25.3K 0.18% 70
2018
Q1 		$232K Sell
4,755
-1,108
-19% -$51.6K 0.21% 69
2017
Q4 		$260K Sell
5,863
-2,121
-27% -$98K 0.22% 67
2017
Q3 		$405K Sell
7,984
-687
-8% -$34.9K 0.38% 61
2017
Q2 		$467K Sell
8,671
-1,133
-12% -$60.4K 0.43% 61
2017
Q1 		$517K Sell
9,804
-33
-0.3% -$1.67K 0.49% 60
2016
Q4 		$474K Buy
+9,837
New +$486K 0.48% 59

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

United Bank (Georgia)'s GSK Position: Q2 2026 in Review

United Bank (Georgia) reduced its GSK (GSK) stake by 5.2% in Q2 2026, selling an estimated $106K and leaving 36,087 shares worth $1.89M. The position accounts for 0.58% of the portfolio, ranked #48.

United Bank (Georgia) first reported a position in GSK in Q4 2016 and has held it in 22 quarters since. The position peaked at $2.1M in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • United Bank (Georgia) held 36,087 shares of GSK worth $1.89M as of Q2 2026.
  • United Bank (Georgia) sold 1,996 GSK shares in Q2 2026, an estimated $106K.
  • GSK made up 0.58% of United Bank (Georgia)'s portfolio in Q2 2026, its #48 holding.
  • United Bank (Georgia) first reported a position in GSK in Q4 2016 and has held it in 22 quarters since.
  • United Bank (Georgia)'s GSK position peaked at $2.1M in Q1 2026.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on United Bank (Georgia)'s 13F filing for Q2 2026, filed 10 Aug 2026.